Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 340
we******** 2025.06.04 0 340
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 268
we******** 2025.05.26 0 268
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 222
we******** 2025.04.16 0 222
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 163
we******** 2025.04.03 0 163
30 Prestige Biopharma to Present Preliminary Phase 1/2a Results of Pancreatic Cancer Antibody PBP1510 at AACR 2025
we******** | 2025.04.01 | Votes 0 | Views 260
we******** 2025.04.01 0 260
29 Prestige Biopharma Files Patent for Early Pancreatic Cancer Diagnostic Technology
we******** | 2025.01.22 | Votes 0 | Views 184
we******** 2025.01.22 0 184
28 Prestige Biopharma Secures Japanese Patent for Antibody Drug Candidate PBP1710 Targeting Solid Tumors
김** | 2025.01.21 | Votes 0 | Views 198
김** 2025.01.21 0 198
27 Prestige Biopharma Group Accelerates Drug Development with New R&D Hub Backed by KRW 200 Billion Investment
we******** | 2024.11.19 | Votes 0 | Views 230
we******** 2024.11.19 0 230
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 214
김** 2024.11.15 0 214
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 300
김** 2024.11.15 0 300